Calendar of Events & Lectures

Today
This Week

Monday, April 10, 2017

Home Sweet Home: Epigenetic Paths of Stem Cells In and Out of Their Niche

| CASPARY AUDITORIUM
Academic Lectures, Thesis Presentations
Rene Adam, graduate fellow, The Rockefeller University

Immune Processing and Recognition of Tumors

| AUDITORIUM, ROCKEFELLER RESEARCH LABORATORIES, MSKCC, 430 E. 67TH ST.
Tri-Institutional Events (at MSK & WCM), Other Tri-Institutional Events
Max Krummel, Ph.D., professor, department of pathology, University of California, San Francisco

Thoughts on Druggability: Lessons from Challenging Targets

| M-107 MSKCC, 1275 YORK AVE.
Tri-Institutional Events (at MSK & WCM), Other Tri-Institutional Events
Percy Carter, Ph.D., vice president and head of discovery chemistry and molecular technologies, Drug Discovery Research, Bristol-Myers Squibb Company

Hep C Seminar: Mechanisms of RIG-I–like Receptor Activation and Manipulation by Viral Pathogens

| 305 WRB
Michaela U. Gack, Ph.D., professor, department of microbiology, University of Chicago

Tri-Institutional Calendars

The close proximity among the three institutions which comprise the Tri-I has led to a culture that encourages interinstitutional interactions and shared resources, including access to lectures and seminars from internationally renowned scientists and clinicians:

Upcoming Events

Microscale Biophysics of the Ocean: A Single-Cell Perspective on the Biological Carbon Pump

| CARSON FAMILY AUDITORIUM (CRC)

Liquid Biopsies in Pediatric Solid Tumors

| CARSON FAMILY AUDITORIUM (CRC)

Spying on the Immune System

| CASPARY AUDITORIUM
The Philip Levine Memorial Lecture

News

Some mammals can hit pause on a pregnancy. Understanding how that happens could help us treat cancer.

New study reveals the molecular brake that lets embryonic stem cells enter suspended animation, while retaining the ability to develop normally—which could shed light on abnormal cell growth in humans.

New engineered derivative of a natural molecule could translate into a powerful replacement for IVIG therapy for a wide array of autoimmune disorders

In experiments with mice, the new molecule accomplished the same job at a hundredth of the dose.

This new insight into T cell receptors may improve cancer immunotherapies

Researchers discovered that a crucial first step in the signaling system operates differently than previously thought, an insight that could lead to the next generation of treatments.

Room Reservation Calendar